Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elihu Estey

Showing results (61-70 of 158) with videos related to

Pageof 16
Sort By:
Blood|December 24, 2005
Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemiaElihu Estey, Guillermo Garcia-Manero, Alessandra Ferrajoli, et al.
Cancer|August 7, 2008
The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromesApostolia Maria Tsimberidou, Elihu Estey, Sijin Wen, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 17, 2013
Single-agent liposomal all-trans-retinoic Acid as initial therapy for acute promyelocytic leukemia: 13-year follow-up dataPreetesh Jain, Hagop Kantarjian, Elihu Estey, et al.
Leukemia Research|February 27, 2018
Widespread use of measurable residual disease in acute myeloid leukemia practiceZachary D Epstein-Peterson, Sean M Devlin, Eytan M Stein, et al.
Leukemia Research|October 6, 2009
Clinical correlation of circulating heat shock protein 70 in acute leukemiaChen-Hsiung Yeh, Richard Tseng, Alison Hannah, et al.
Hematology. American Society of Hematology. Education Program|November 10, 2001
New Developments in the Therapy of Acute Myelocytic LeukemiaNorbert C. Gorin, Elihu Estey, Richard J. Jones, et al.
Blood|October 14, 2006
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)Elihu Estey, Marcos de Lima, Raoul Tibes, et al.
Leukemia Research|February 13, 2002
Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levelsSima Jeha, Franklin O Smith, Elihu Estey, et al.
Blood|June 18, 2011
Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantationMin Fang, Barry Storer, Elihu Estey, et al.
British Journal of Haematology|January 18, 2006
The role of gemtuzumab ozogamicin in acute leukaemia therapyApostolia-Maria Tsimberidou, Francis J Giles, Elihu Estey, et al.
Pageof 16

Showing results (61-70 of 158) with videos related to

Sort By:
Pageof 16
Blood|December 24, 2005
Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemiaElihu Estey, Guillermo Garcia-Manero, Alessandra Ferrajoli, et al.
Cancer|August 7, 2008
The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromesApostolia Maria Tsimberidou, Elihu Estey, Sijin Wen, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 17, 2013
Single-agent liposomal all-trans-retinoic Acid as initial therapy for acute promyelocytic leukemia: 13-year follow-up dataPreetesh Jain, Hagop Kantarjian, Elihu Estey, et al.
Leukemia Research|February 27, 2018
Widespread use of measurable residual disease in acute myeloid leukemia practiceZachary D Epstein-Peterson, Sean M Devlin, Eytan M Stein, et al.
Leukemia Research|October 6, 2009
Clinical correlation of circulating heat shock protein 70 in acute leukemiaChen-Hsiung Yeh, Richard Tseng, Alison Hannah, et al.
Hematology. American Society of Hematology. Education Program|November 10, 2001
New Developments in the Therapy of Acute Myelocytic LeukemiaNorbert C. Gorin, Elihu Estey, Richard J. Jones, et al.
Blood|October 14, 2006
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)Elihu Estey, Marcos de Lima, Raoul Tibes, et al.
Leukemia Research|February 13, 2002
Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levelsSima Jeha, Franklin O Smith, Elihu Estey, et al.
Blood|June 18, 2011
Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantationMin Fang, Barry Storer, Elihu Estey, et al.
British Journal of Haematology|January 18, 2006
The role of gemtuzumab ozogamicin in acute leukaemia therapyApostolia-Maria Tsimberidou, Francis J Giles, Elihu Estey, et al.
Pageof 16